Eradivir, Inc.
- Biotech or pharma, therapeutic R&D
Eradivir is developing drugs that bind to diseased cells, serving as a beacon to guide the immune system.Please stop by to attend our presentation on Tuesday, June 17 at 4:00 PM in Room 153A to learn more about the innovations.
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
){kind=logo}